Evaluation of Universal Antenatal Screening for Group B Streptococcus

Invasive group B streptococcal disease is a leading cause of illness in the first week of life. Universal culture-based screening in the third trimester of pregnancy was recommended in the United States in 2002. This study shows that this policy has been associated with a decrease in the incidence o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2009-06, Vol.360 (25), p.2626-2636
Hauptverfasser: Van Dyke, Melissa K, Phares, Christina R, Lynfield, Ruth, Thomas, Ann R, Arnold, Kathryn E, Craig, Allen S, Mohle-Boetani, Janet, Gershman, Ken, Schaffner, William, Petit, Susan, Zansky, Shelley M, Morin, Craig A, Spina, Nancy L, Wymore, Kathryn, Harrison, Lee H, Shutt, Kathleen A, Bareta, Joseph, Bulens, Sandra N, Zell, Elizabeth R, Schuchat, Anne, Schrag, Stephanie J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Invasive group B streptococcal disease is a leading cause of illness in the first week of life. Universal culture-based screening in the third trimester of pregnancy was recommended in the United States in 2002. This study shows that this policy has been associated with a decrease in the incidence of group B streptococcal disease. Populations that may benefit from additional preventive measures are identified. Universal culture-based screening in the third trimester of pregnancy was recommended in the United States in 2002. This study shows that this policy has been associated with a decrease in the incidence of group B streptococcal disease. Invasive group B streptococcal disease emerged in the 1970s as a leading infectious cause of illness and death in the first week of life. 1 Clinical trials in the 1980s showed that early-onset group B streptococcal disease (i.e., occurring in infants
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa0806820